Tag Archives: biotechnology

PTO Issues Final Rule to Implement Prioritized Examination Track (Track I)

The following is from the Schwegman, Lundberg & Woessner Newsletter, April 6, 2011. The Patent and Trademark Office on April 4, 2011, issued a final rule to implement prioritized examination upon an applicant’s request and payment of a $4,000 request … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , , , , , , | Leave a comment

Federal Court Hears Myriad Gene Case This Morning

The following is a guest post from Ann McCrackin. I attended oral arguments at the CAFC on Monday for Association for Molecular Pathology v. Myriad Genetics, Inc.   The three-judge panel included Judge Bryson, Judge Lourie and Judge Moore.  Most of the … Continue reading

Posted in Burden of Proof | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Banning Stem Cell Research — Or Cloning? Or Both?

A front-page article in the Minneapolis StarTribune entitled “Stakes High In Cloning Debate” (March 30, 2011) discusses a bill recently introduced into the Minnesota legislature to criminalize “human cloning.” The article reflects on the confusion surrounding what it is, exactly, that groups … Continue reading

Posted in Stem Cells/Cloning | Tagged , , , , , , , , , , , | Leave a comment

Innovation Toys And Analogous Art – Defender Against Hindsight?

There is nothing particularly surprising in the recent Fed. Cir. decision of Innovation Toys v. MGA Entertainment, App. No. 2010-1290 (Fed. Cir. March 21, 2011) (a copy is available at the end of this post), which reversed a District Court finding … Continue reading

Posted in Obviousness | Tagged , , , , , , , , , , , , , , , | Leave a comment